CelltiX Nebulizer

How CelltiX Help Reduce Symptoms of COVID-19?



In addition, many leading universities and research centres in Malaysia are actively involved in conducting research on the potential of bioactive factors for clinical use. Among them are:


  1. Gupta, A., Kashte, S., Gupta, M., Rodriguez, H. C., Gautam, S. S., & Kadam, S. (2020). Mesenchymal stem cells and exosome research for COVID-19: current status and future perspective. Human cell33(4), 907–918. https://doi.org/10.1007/s13577-020-00407-w. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418088/
  2. Gurunathan, S., Kang, M. H., & Kim, J. H. (2021). Diverse effects of exosomes on COVID-19: A perspective of progress from transmission to therapeutic developments. Frontiers in Immunology, 12. https://www.frontiersin.org/articles/10.3389/fimmu.2021.716407/full
  3. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., Xiao, Y., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England)395(10223), 497–506. https://pubmed.ncbi.nlm.nih.gov/31986264/
  4. de la Rica, R., Borges, M., & Gonzalez-Freire, M. (2020). COVID-19: In the Eye of the Cytokine Storm. Frontiers in immunology11, 558898. https://doi.org/10.3389/fimmu.2020.558898. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541915/
  5. Khadke, S., Ahmed, N., Ahmed, N., Ratts, R., Raju, S., Gallogly, M., … & Sohail, M. R. (2020). Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents. Virology journal17(1), 1-18. https://virologyj.biomedcentral.com/articles/10.1186/s12985-020-01415-w#citeas
  6. Li, L., Huang, Q., Wang, D. C., Ingbar, D. H., & Wang, X. (2020). Acute lung injury in patients with COVID-19 infection. Clinical and translational medicine10(1), 20–27. https://doi.org/10.1002/ctm2.16. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240840/
  7. Clinical Spectrum of SARS-CoV-2 Infection, NIH. https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/
  8. Spagnolo, P., Balestro, E., Aliberti, S., Cocconcelli, E., Biondini, D., Casa, G. D., Sverzellati, N., & Maher, T. M. (2020). Pulmonary fibrosis secondary to COVID-19: a call to arms?. The Lancet. Respiratory medicine8(8), 750–752. https://doi.org/10.1016/S2213-2600(20)30222-8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228737/
  9. Wadman, M., Couzin-Frankel, J., Kaiser, J., & Matacic, C. (2020). A rampage through the body. https://www.science.org/doi/abs/10.1126/science.368.6489.356
  10. Zaim, S., Chong, J. H., Sankaranarayanan, V., & Harky, A. (2020). COVID-19 and Multiorgan Response. Current problems in cardiology45(8), 100618. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187881/
  11. Yu, B., Zhang, X., & Li, X. (2014). Exosomes derived from mesenchymal stem cells. International journal of molecular sciences15(3), 4142–4157. https://doi.org/10.3390/ijms15034142. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975389/
  12. Phinney, D. G., & Pittenger, M. F. (2017). Concise review: MSC‐derived exosomes for cell‐free research. Stem cells35(4), 851-858. https://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/stem.2575
  13. Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., … & Wan, E. Y. (2021). Post-acute COVID-19 syndrome. Nature medicine27(4), 601-615. https://www.nature.com/articles/s41591-021-01283-z#citeas
  14. Garis Panduan KKM Post-COVID-19. https://covid-19.moh.gov.my/garis-panduan/garis-panduan-kkm/ANNEX_50_POST_COVID-19_MANAGEMENT_PROTOCOL_12JULY2021.pdf
  15. Jayaramayya, K., Mahalaxmi, I., Subramaniam, M. D., Raj, N., Dayem, A. A., Lim, K. M., Kim, S. J., An, J. Y., Lee, Y., Choi, Y., Raj, A., Cho, S. G., & Vellingiri, B. (2020). Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment. BMB reports53(8), 400–412. https://doi.org/10.5483/BMBRep.2020.53.8.121. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473478/
  16. Gurunathan, S., Kang, M. H., & Kim, J. H. (2021). Diverse effects of exosomes on COVID-19: A perspective of progress from transmission to therapeutic developments. Frontiers in Immunology, 12. https://www.frontiersin.org/articles/10.3389/fimmu.2021.716407/full
  17. Drew, D. A., Guo, C. G., Lee, K. A., Nguyen, L. H., Joshi, A. D., Lo, C. H., … & Chan, A. T. (2021). Aspirin and NSAID use and the risk of COVID-19. medRxiv. https://covid-19.cochrane.org/studies/crs-13265944
  18. Gardin, C., Ferroni, L., Chachques, J. C., & Zavan, B. (2020). Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?. Journal of clinical medicine9(9), 2762. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565764/
  19. Bari, E., Ferrarotti, I., Saracino, L., Perteghella, S., Torre, M. L., Richeldi, L., & Corsico, A. G. (2021). Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Research to Treat the Long-Term Lung Sequelae?. Cells10(5), 1203. https://doi.org/10.3390/cells10051203. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155949/
  20. The Jerusalem Post. https://www.jpost.com/health-science/covid-90-percent-of-patients-treated-with-new-israeli-drug-discharged-in-5-days-67596
  21. Lee, J. H., Park, J., & Lee, J. W. (2019). Therapeutic use of mesenchymal stem cell-derived extracellular vesicles in acute lung injury. Transfusion59(S1), 876–883. https://doi.org/10.1111/trf.14838. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368889/
  22. Abdelgawad, M., Bakry, N. S., Farghali, A. A., Abdel-Latif, A., & Lotfy, A. (2021). Mesenchymal stem cell-based research and exosomes in COVID-19: current trends and prospects. Stem cell research & research, 12(1), 1-20. https://stemcellres.biomedcentral.com/articles/10.1186/s13287-021-02542-z#citeas
  23. Schulman, I. H., Balkan, W., & Hare, J. M. (2018). Mesenchymal stem cell research for aging frailty. Frontiers in nutrition5, 108. https://www.frontiersin.org/articles/10.3389/fnut.2018.00108/full
  24. Srinivasan, A., & Sundar, I. K. (2021). Recent updates on the role of extracellular vesicles in the pathogenesis of allergic asthma. Extracellular vesicles and circulating nucleic acids2, 127–147. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372030/
  25. Maremanda, K. P., Sundar, I. K., & Rahman, I. (2019). Protective role of mesenchymal stem cells and mesenchymal stem cell-derived exosomes in cigarette smoke-induced mitochondrial dysfunction in mice. Toxicology and applied pharmacology385, 114788. https://doi.org/10.1016/j.taap.2019.114788. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894395/
  26. Xu, B., Gan, C. X., Chen, S. S., Li, J. Q., Liu, M. Z., & Guo, G. H. (2020). BMSC-derived exosomes alleviate smoke inhalation lung injury through blockade of the HMGB1/NF-κB pathway. Life sciences257, 118042. https://doi.org/10.1016/j.lfs.2020.118042. https://pubmed.ncbi.nlm.nih.gov/32621926/
  27. Panagiotou, N., Neytchev, O., Selman, C., & Shiels, P. G. (2018). Extracellular Vesicles, Ageing, and Therapeutic Interventions. Cells7(8), 110. https://doi.org/10.3390/cells7080110. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115766/
  28. Clinical Trial NCT04491240. ​https://www.clinicaltrials.gov/ct2/show/results/NCT04491240
  29. Chu, M., Wang, H., Bian, L., Huang, J., Wu, D., Fei, F., … & Xia, J. (2020). Nebulization Research for COVID-19 Pneumonia with Embryonic Mesenchymal Stem Cells-Derived Exosomes. https://europepmc.org/article/PPR/PPR233088
  30. Zambrano, G. M. T., Ahmed, Y. M., Carmenate, Y. V., & Elsadawy, M. E. (2021). Stem cell nebulization research for COVID-19 infection: radiological and clinical outcomes. Egyptian Journal of Radiology and Nuclear Medicine, 52(1), 1-11. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079845/pdf/43055_2021_Article_492.pdf
  31. Alzahrani, F. A., Saadeldin, I. M., Ahmad, A., Kumar, D., Azhar, E. I., Siddiqui, A. J., … & Jahan, S. (2020). The potential use of mesenchymal stem cells and their derived exosomes as immunomodulatory agents for COVID-19 patients. Stem Cells International2020. https://www.hindawi.com/journals/sci/2020/8835986/​